¼¼°èÀÇ ÀǾàǰ ¼öŹ Æ÷Àå ½ÃÀå
Pharmaceutical Contract Packaging
»óǰÄÚµå : 1542792
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 198 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Á¦¾à ¼öŹ Æ÷Àå ¼¼°è ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 572¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î Àü¸Á

2023³â¿¡ 386¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ÀǾàǰ ¼öŹ Æ÷Àå ¼¼°è ½ÃÀåÀº 2023³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 5.8% ¼ºÀåÇÏ¿© 2030³â¿¡´Â 572¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ 1Â÷ Æ÷Àå ºÎ¹®Àº CAGR 5.4%¸¦ ±â·ÏÇÏ¿© ºÐ¼® ±â°£ Á¾·á ½ÃÁ¡¿¡ 257¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. 2Â÷ Æ÷Àå ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 7.2%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀå 104¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 5.3%·Î ¼ºÀå Àü¸Á

¹Ì±¹ÀÇ ÀǾàǰ ¼öŹ Æ÷Àå ½ÃÀåÀº 2023³â 104¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 89¾ï ´Þ·¯ ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2030³â°£ÀÇ ºÐ¼® ±â°£ µ¿¾È 5.3%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 4.9%¿Í 4.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ 4.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ÀǾàǰ À§Å¹Æ÷Àå ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ Á¤¸®

ÀǾàǰ ¼öŹ Æ÷ÀåÀ̶õ ¹«¾ùÀ̸ç, ¿Ö Áß¿äÇѰ¡?

ÀǾàǰ ¼öŹ Æ÷ÀåÀº ÀǾàǰ Æ÷ÀåÀ» Àü¹® Á¦3ÀÚ ¼­ºñ½º Á¦°ø¾÷ü¿¡ À§Å¹ÇÏ´Â °ÍÀ» ÀǹÌÇÕ´Ï´Ù. ÀÌ ÇÁ·Î¼¼½º¿¡´Â Æ÷ÀåÀç ¼³°è, Á¦Á¶, Á¶¸³, ¶óº§¸µ, ÀϷùøÈ£ ºÎ¿©, ǰÁú º¸Áõ µî ´Ù¾çÇÑ ¼­ºñ½º°¡ Æ÷ÇԵ˴ϴÙ. ÀǾàǰ ¼öŹ Æ÷ÀåÀÇ Á߿伺Àº Á¦Á¶¾÷ü¿¡ À¯¿¬¼º, ºñ¿ë È¿À²¼º ¹× ÷´Ü ±â¼ú¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Á¦°øÇÏ´Â ´É·Â¿¡ ÀÖ½À´Ï´Ù. ¼öŹ Æ÷Àå¾÷üÀÇ Àü¹®¼º°ú ÀÚ¿øÀ» Ȱ¿ëÇϸé Á¦¾àȸ»ç´Â ÀǾàǰ °³¹ß ¹× ¸¶ÄÉÆÃÀÇ ÇÙ½É ¾÷¹«¿¡ ÁýÁßÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼öŹ Æ÷Àå¾÷ü´Â Ãֽо÷°è Ç¥Áذú °¡À̵å¶óÀÎÀ» Àß ¾Ë°í Àֱ⠶§¹®¿¡ ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°ÇÀ» ÁؼöÇÒ ¼ö ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ Æ÷ÀåµÈ Á¦Ç°ÀÌ ÇÊ¿äÇÑ ¾ÈÀü¼º ¹× À¯È¿¼º ±âÁØÀ» ÃæÁ·ÇÏ¿© ±Ã±ØÀûÀ¸·Î ȯÀÚÀÇ °Ç°­À» º¸È£ÇÒ ¼ö ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¾î¶»°Ô ÀǾàǰ ¼öŹ Æ÷ÀåÀ» Çü¼ºÇϰí Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº ÀǾàǰ ¼öŹ Æ÷ÀåÀÇ ´É·Â°ú È¿À²¼ºÀ» Å©°Ô Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. °¡Àå ÁÖ¸ñÇÒ ¸¸ÇÑ Çõ½Å Áß Çϳª´Â À§Á¶ ÀǾàǰÀ» ¹æÁöÇÏ°í °ø±Þ¸Á ¹«°á¼ºÀ» º¸ÀåÇÏ´Â µ¥ ÇʼöÀûÀÎ °í±Þ Á÷·ÄÈ­ ¹× ÃßÀû¼º ¼Ö·ç¼ÇÀÇ µµÀÔÀÔ´Ï´Ù. ÀÚµ¿È­¿Í ·Îº¿°øÇÐ ¶ÇÇÑ Æ÷Àå °øÁ¤À» Çõ½ÅÇÏ¿© ´õ ³ôÀº Á¤È®¼º, Àϰü¼º, ¼Óµµ¸¦ °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á ÀÎÀû ¿À·ù¸¦ ÁÙÀÌ°í »ý»ê¼ºÀ» Çâ»ó½Ã۰í ÀÖÀ¸¸ç, QR ÄÚµå ¹× RFID ÅÂ±×¿Í °°Àº ½º¸¶Æ® Æ÷Àå ±â¼úÀ» »ç¿ëÇÏ¿© À¯Åë ³×Æ®¿öÅ© Àü¹Ý¿¡ °ÉÃÄ ÀǾàǰÀ» ´õ Àß ÃßÀûÇÏ°í ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÃßÀû ¹× ¸ð´ÏÅ͸µÀÌ °¡´ÉÇØÁý´Ï´Ù. ¶ÇÇÑ, º¸´Ù Áö¼Ó °¡´ÉÇϰí ȯ°æ ģȭÀûÀÎ Æ÷ÀåÀç °³¹ß µî Æ÷Àå Àç·áÀÇ Ã·´ÜÈ­¸¦ ÅëÇØ ȯ°æ ¹®Á¦¿¡ ´ëÀÀÇϰí ģȯ°æ Æ÷Àå ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ºÎÀÀÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀº ÀǾàǰ ¼öŹ Æ÷ÀåÀ» ´õ¿í ½Å·ÚÇÒ ¼ö ÀÖ°í ¾ÈÀüÇϸç, ¾÷°èÀÇ º¯È­ÇÏ´Â ¿ä±¸¿¡ ÀûÀÀÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù.

ÀǾàǰ ¼öŹ Æ÷ÀåÀÇ °úÁ¦´Â?

ÀǾàǰ ¼öŹ Æ÷Àå¿¡´Â ¸¹Àº ÀåÁ¡ÀÌ ÀÖÁö¸¸, ÃÖÀûÀÇ ¼º´ÉÀ» º¸ÀåÇϱâ À§Çؼ­´Â ¸î °¡Áö °úÁ¦°¡ ÀÖ½À´Ï´Ù. ÁÖ¿ä °úÁ¦ Áß Çϳª´Â °¢ Áö¿ª¿¡¼­ ½Ã½Ã°¢°¢ º¯È­ÇÏ´Â ´Ù¾çÇÑ ±ÔÁ¦ ¿ä°ÇÀ» ÁؼöÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ´Â Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ°ú »õ·Î¿î ±ÔÁ¦¿¡ ´ëÇÑ ÀûÀÀÀÌ ÇÊ¿äÇϸç, ÀÌ´Â ÀÚ¿øÀ» ÁýÁß½Ãų ¼ö ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ Å« °úÁ¦´Â °ø±Þ¸ÁÀÇ ¾ÈÀü°ú ¹«°á¼ºÀ» º¸ÀåÇÏ´Â °ÍÀ¸·Î, ƯÈ÷ À§Á¶ ÇàÀ§ Áõ°¡·Î ÀÎÇØ °­·ÂÇÑ ÀϷùøÈ£¿Í ÃßÀû ½Ã½ºÅÛÀÌ ÇÊ¿äÇÕ´Ï´Ù. ¶ÇÇÑ, ³ôÀº ¼öÁØÀÇ Ç°Áú°ú ¾ÈÀü¼ºÀ» À¯ÁöÇϸ鼭 ´Ù¾çÇÑ Æ÷Àå ÇüÅÂ¿Í Àç·á¸¦ °ü¸®ÇÏ´Â º¹À⼺Àº °íµµÀÇ ¹°·ù ¹× ǰÁú °ü¸® ¸ÞÄ¿´ÏÁòÀ» ÇÊ¿ä·Î ÇÕ´Ï´Ù. ¶ÇÇÑ, ¼öŹ Æ÷Àå ±â¾÷Àº ÷´Ü ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ ¹× ¿î¿µ È¿À²¼ºÀ» À¯ÁöÇϸ鼭 µ¿½Ã¿¡ ºñ¿ë Àý°¨¿¡ ´ëÇÑ ¾Ð¹ÚÀ» À̰ܳ»¾ß ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ »óÃæµÇ´Â ¿ä±¸ »çÇ×ÀÇ ±ÕÇüÀ» ¸ÂÃß´Â °ÍÀº ÀǾàǰ ¼öŹ Æ÷Àå ¼­ºñ½ºÀÇ ¼º°ø°ú Áö¼Ó°¡´É¼º¿¡ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

ÀǾàǰ ¼öŹ Æ÷Àå ½ÃÀåÀÇ ¼ºÀå ¿äÀÎÀº ¹«¾ùÀϱî?

Á¦¾à ¼öŹ Æ÷Àå ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ù°, ¸¸¼º ÁúȯÀÇ È®»ê°ú °í·ÉÈ­·Î ÀÎÇØ Àü ¼¼°èÀûÀ¸·Î ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÀÌ¿¡ µû¶ó È¿À²ÀûÀ̰í È®À强ÀÌ ³ôÀº ÆÐŰ¡ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÚµ¿È­, ½º¸¶Æ® ÆÐŰ¡, ÷´Ü ÃßÀû ½Ã½ºÅÛ µîÀÇ ±â¼ú ¹ßÀüÀº ÆÐŰ¡ ÇÁ·Î¼¼½ºÀÇ È¿À²¼º°ú ¾ÈÀü¼ºÀ» Çâ»ó½ÃÄÑ Á¦¾à»çµéÀÌ ÀÌ·¯ÇÑ ¼­ºñ½º¸¦ ¾Æ¿ô¼Ò½ÌÇϵµ·Ï À¯µµÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Áö¼Ó°¡´É¼º¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ȯ°æ ģȭÀûÀÎ Æ÷ÀåÀç°¡ °³¹ßµÇ¸é¼­ ȯ°æ ¹®Á¦¿¡ ´ëÀÀÇÏ°í ¼ÒºñÀÚ ¼±È£µµ¿¡ ºÎÇÕÇϴ ģȯ°æ Æ÷ÀåÀç°¡ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. ±ÔÁ¦¿¡ ´ëÇÑ ¾Ð¹Ú°ú ¾ö°ÝÇÑ ±âÁØÀ» ÁؼöÇØ¾ß ÇÏ´Â Á¦¾à»çµéÀº ¾÷°è °¡À̵å¶óÀÎÀ» ÁؼöÇÒ ¼ö ÀÖ´Â Àü¹® Æ÷Àå¾÷ü¿Í ÆÄÆ®³Ê½ÊÀ» ¸Î´Â Ãß¼¼ÀÔ´Ï´Ù. ¶ÇÇÑ, Àü ¼¼°èÀûÀ¸·Î ÀǾàǰ °ø±Þ¸ÁÀÌ È®´ëµÇ°í Æ÷Àå ¿ä±¸»çÇ×ÀÌ º¹ÀâÇØÁü¿¡ µû¶ó Æ÷Àå À§Å¹¾÷üÀÇ Àü¹®¼º°ú ¿ª·®ÀÌ ´õ¿í ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ÀǾàǰ ¼öŹ Æ÷Àå ½ÃÀåÀÇ °ß°íÇÑ ¼ºÀå°ú ¹ßÀü¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹½Ã(ÃÑ 57°Ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Pharmaceutical Contract Packaging Market to Reach US$57.2 Billion by 2030

The global market for Pharmaceutical Contract Packaging estimated at US$38.6 Billion in the year 2023, is expected to reach US$57.2 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Primary Packaging, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$25.7 Billion by the end of the analysis period. Growth in the Secondary Packaging segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$10.4 Billion While China is Forecast to Grow at 5.3% CAGR

The Pharmaceutical Contract Packaging market in the U.S. is estimated at US$10.4 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$8.9 Billion by the year 2030 trailing a CAGR of 5.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Pharmaceutical Contract Packaging Market - Key Trends and Drivers Summarized

What Is Pharmaceutical Contract Packaging and Why Is It Important?

Pharmaceutical contract packaging involves outsourcing the packaging of pharmaceutical products to specialized third-party service providers. This process encompasses a wide range of services, including the design, production, and assembly of packaging materials, as well as labeling, serialization, and quality assurance. The importance of pharmaceutical contract packaging lies in its ability to offer manufacturers flexibility, cost efficiency, and access to advanced technologies. By leveraging the expertise and resources of contract packagers, pharmaceutical companies can focus on their core activities of drug development and marketing. Additionally, contract packaging ensures compliance with stringent regulatory requirements, as these service providers are well-versed in the latest industry standards and guidelines. This guarantees that the packaged products meet the necessary safety and efficacy criteria, ultimately safeguarding patient health.

How Are Technological Advancements Shaping Pharmaceutical Contract Packaging?

Technological advancements are significantly enhancing the capabilities and efficiency of pharmaceutical contract packaging. One of the most notable innovations is the implementation of advanced serialization and traceability solutions, which are crucial for preventing counterfeit drugs and ensuring supply chain integrity. Automation and robotics are also transforming the packaging process, enabling higher precision, consistency, and speed, thereby reducing human error and increasing productivity. The use of smart packaging technologies, such as QR codes and RFID tags, allows for better tracking and monitoring of pharmaceutical products throughout the distribution network. Furthermore, advancements in packaging materials, including the development of more sustainable and eco-friendly options, are addressing environmental concerns and meeting the growing demand for green packaging solutions. These technological strides are making pharmaceutical contract packaging more reliable, secure, and adaptable to the evolving needs of the industry.

What Are the Key Challenges in Pharmaceutical Contract Packaging?

Despite its many benefits, pharmaceutical contract packaging faces several challenges that must be addressed to ensure optimal performance. One of the primary challenges is maintaining compliance with diverse and ever-changing regulatory requirements across different regions. This necessitates continuous monitoring and adaptation to new regulations, which can be resource-intensive. Another significant challenge is ensuring the security and integrity of the supply chain, particularly in the face of rising counterfeit activities and the need for robust serialization and traceability systems. Additionally, the complexity of managing multiple packaging formats and materials, while maintaining high standards of quality and safety, requires sophisticated logistics and quality control mechanisms. Contract packagers must also navigate the pressures of cost containment while investing in advanced technologies and maintaining operational efficiency. Balancing these competing demands is critical for the success and sustainability of pharmaceutical contract packaging services.

What Factors Are Driving Growth in the Pharmaceutical Contract Packaging Market?

The growth in the pharmaceutical contract packaging market is driven by several factors. Firstly, the increasing demand for pharmaceutical products globally, spurred by the rising prevalence of chronic diseases and an aging population, is boosting the need for efficient and scalable packaging solutions. Technological advancements, such as automation, smart packaging, and advanced traceability systems, are enhancing the efficiency and security of the packaging process, attracting more pharmaceutical companies to outsource these services. Additionally, the growing focus on sustainability and the development of eco-friendly packaging materials are addressing environmental concerns and aligning with consumer preferences. Regulatory pressures and the need for compliance with stringent standards are also driving pharmaceutical companies to partner with specialized contract packagers who can ensure adherence to industry guidelines. Furthermore, the expansion of the global pharmaceutical supply chain, coupled with the increasing complexity of packaging requirements, is necessitating the expertise and capabilities of contract packaging providers. These factors collectively contribute to the robust growth and evolution of the pharmaceutical contract packaging market.

Select Competitors (Total 57 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â